A股異動 | 博思軟件(300525.SZ)漲停 擬2.43億元購買博思致新49%股權
格隆匯6月18日丨博思軟件(300525.SZ)漲停,報34.19元,總市值95億元。博思軟件本週一公佈,公司擬通過發行股份的方式購買博思致新49%股權,交易作價為2.43億元,發行價格22.20元/股,發行股份數量為1094.77萬股。同時,上市公司擬向公司控股股東、實際控制人陳航定向發行不超過720.7207萬股,募集配套資金1.6億元,發行價格22.20元/股。用於支付本次交易費用、政務行業通用服務平台項目及上市公司補充流動資金,募集配套資金總額不超過本次交易中以發行股份方式購買資產的交易價格的100%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.